| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 86/11/11 | 100/09/29 | 羅智先 | 盧麗安 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.07(Q2) | 82.58 | 2.12 | 1.32% |
| 實收資本額 | 已發行普通股 | ||
| 7,907,392,220 | 790,739,222 | ||
| 主要經營業務 | |||
| 原料藥、針劑製劑之研發、產銷及相關產品之諮詢及技術服務業務生物技術服務國際貿易業 | |||
| 公司網址 | |||
| scinopharm.com.tw | |||
神隆(1789) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 183,059 | 189,826 | -7.1% | -3.6% | 1,783,525 | 2,024,207 | -11.9% |
| 2023/07 | 197,135 | 290,904 | -46.5% | -32.2% | 1,600,466 | 1,834,381 | -12.8% |
| 2023/06 | 368,628 | 288,817 | 89.3% | 27.6% | 1,403,331 | 1,543,477 | -9.1% |
| 2023/05 | 194,709 | 355,127 | 1.6% | -45.2% | 1,034,703 | 1,254,660 | -17.5% |
| 2023/04 | 191,564 | 161,594 | -22.6% | 18.5% | 839,994 | 899,533 | -6.6% |
| 2023/03 | 247,394 | 301,546 | 34% | -18% | 648,430 | 737,939 | -12.1% |
| 2023/02 | 184,673 | 192,401 | -14.6% | -4% | 401,036 | 436,393 | -8.1% |
| 2023/01 | 216,363 | 243,992 | -54.6% | -11.3% | 216,363 | 243,992 | -11.3% |
| 2022/12 | 476,258 | 167,287 | 56.5% | 184.7% | 3,264,045 | 2,762,335 | 18.2% |
| 2022/11 | 304,216 | 310,225 | 29.2% | -1.9% | 2,787,787 | 2,595,048 | 7.4% |
| 2022/10 | 235,378 | 241,819 | 5.1% | -2.7% | 2,483,571 | 2,284,823 | 8.7% |
| 2022/09 | 223,986 | 213,606 | 18% | 4.8% | 2,248,193 | 2,043,004 | 10% |
| 2022/08 | 189,826 | 232,901 | -34.7% | -18.5% | 2,024,207 | 1,829,398 | 10.6% |
| 2022/07 | 290,904 | 207,723 | 0.7% | 40% | 1,834,381 | 1,596,497 | 14.9% |
| 2022/06 | 288,817 | 247,008 | -18.7% | 16.9% | 1,543,477 | 1,388,774 | 11.1% |
| 2022/05 | 355,127 | 266,566 | 119.8% | 33.2% | 1,254,660 | 1,141,766 | 9.9% |
| 2022/04 | 161,594 | 234,064 | -46.4% | -31% | 899,533 | 875,200 | 2.8% |
| 2022/03 | 301,546 | 241,169 | 56.7% | 25% | 737,939 | 641,136 | 15.1% |
| 2022/02 | 192,401 | 197,578 | -21.1% | -2.6% | 436,393 | 399,967 | 9.1% |
| 2022/01 | 243,992 | 202,389 | 45.8% | 20.5% | 243,992 | 202,389 | 20.5% |
| 2021/12 | 167,287 | 322,402 | -46.1% | -48.1% | 2,762,335 | 3,082,928 | -10.4% |
| 2021/11 | 310,225 | 240,069 | 28.3% | 29.2% | 2,595,048 | 2,760,526 | -6% |
| 2021/10 | 241,819 | 311,527 | 13.2% | -22.4% | 2,284,823 | 2,520,457 | -9.3% |
| 2021/09 | 213,606 | 268,571 | -8.3% | -20.5% | 2,043,004 | 2,208,930 | -7.5% |
| 2021/08 | 232,901 | 146,250 | 12.1% | 59.2% | 1,829,398 | 1,940,359 | -5.7% |
| 2021/07 | 207,723 | 343,506 | -15.9% | -39.5% | 1,596,497 | 1,794,109 | -11% |
| 2021/06 | 247,008 | 212,977 | -7.3% | 16% | 1,388,774 | 1,450,603 | -4.3% |
| 2021/05 | 266,566 | 342,981 | 13.9% | -22.3% | 1,141,766 | 1,237,626 | -7.7% |
| 2021/04 | 234,064 | 352,122 | -2.9% | -33.5% | 875,200 | 894,645 | -2.2% |
| 2021/03 | 241,169 | 181,101 | 22.1% | 33.2% | 641,136 | 542,523 | 18.2% |
| 2021/02 | 197,578 | 202,566 | -2.4% | -2.5% | 399,967 | 361,422 | 10.7% |
| 2021/01 | 202,389 | 158,856 | -37.2% | 27.4% | 202,389 | 158,856 | 27.4% |
| 2020/12 | 322,402 | 384,607 | 34.3% | -16.2% | 3,082,928 | 2,892,783 | 6.6% |
| 2020/11 | 240,069 | 217,531 | -22.9% | 10.4% | 2,760,526 | 2,508,176 | 10.1% |
| 2020/10 | 311,527 | 217,414 | 16% | 43.3% | 2,520,457 | 2,290,645 | 10% |
| 2020/09 | 268,571 | 225,599 | 83.6% | 19% | 2,208,930 | 2,073,231 | 6.5% |
神隆(1789) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 16.42% | -1.60% | 2020Q3 | -16.49% | 2.53% |
| 2023Q1 | -36.17% | -2.74% | 2020Q2 | 67.38% | 10.91% |
| 2022Q4 | 44.15% | 9.99% | 2020Q1 | -33.80% | -7.93% |
| 2022Q3 | -12.52% | 1.73% | 2019Q4 | 19.89% | -1.37% |
| 2022Q2 | 9.16% | 2.03% | 2019Q3 | 10.69% | -4.37% |
| 2022Q1 | 2.59% | 3.50% | 2019Q2 | -20.01% | -10.71% |
| 2021Q4 | 9.95% | -5.30% | 2019Q1 | -10.19% | -2.53% |
| 2021Q3 | -12.49% | -3.45% | 2018Q4 | 5.13% | -0.99% |
| 2021Q2 | 16.61% | -5.04% | 2018Q3 | -17.04% | -0.87% |
| 2021Q1 | -26.64% | 3.20% | 2018Q2 | 14.43% | 3.83% |
| 2020Q4 | 15.25% | 1.80% | 2018Q1 | -3.77% | -1.65% |
評論0